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ABSTRACT 
 
Simultaneous estimation of three component tablets containing Doxylamine succinate 
(DOX),  Pyridoxine  hydrochloride  (PYR)  and  Folic  acid  (FA)  was  carried  out  by  UV 
spectrophotometric  assisted  chemometric  methods.  Four  chemometric  methods  i.e. 
classical least square (CLS), inverse least square (ILS), principal component regression 
(PCR) and partial least squares (PLS) were applied to simultaneous assay of DOX, 
PYR and FA in tablets without any chemical separation and any graphical treatment of 
the overlapping spectra of three drugs. The chemometric calculations were performed 
by using the Chemometrics Toolbox 3.02 software (Kramer, 1995) along with MATLAB 
6. The results of four chemometric methods were statistically compared with each other. 
These  chemometric  calibrations  were  successfully  applied  to  the  marketed  tablets 
without  any  separation  procedure.  Mean  recoveries  (percent)  and  relative  standard 
deviation of ILS, CLS, PCR, PLS methods were found to be 98.77/1.76, 100.59/1.53, 
97.91/1.50, 97.53/1.73 for DOX; 99.79/1.22, 100.22/0.58, 100.31/1.68 and 99.33/1.10 
for  PYR;  99.79/1.37, 100.57/1.56  and 98.38/0.96  for  FA  respectively.  All  of  the four 
chemometric  methods  in  this  study  can  be  satisfactorily  used  for  the  quantitative 
analysis of multi-component dosage form. 
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INTRODUCTION 
 
The development of chemometric methods of 
multi-component  analysis  has  allowed  the 
resolution of the complex spectra of mixtures 
of  analytes 
1.  The  chemometric  quantitative 
analytical techniques have many applications 
and advantages such as the mixtures can be 
analyzed  without  any  separation  procedures 
for  drug  determination;  the  techniques  are 
very easy to apply, very sensitive, useful and 
yet  very  inexpensive  as  compared  to  other 
analytical  techniques  for  simultaneous 
determination  of  compounds  in  multi-
component mixtures. These methods provide 
additional  advantages  where  calibration  can 
be performed by ignoring the concentration of 
all  other  components  except  the  analyte  of 
interest  and  also  the  speed  in  the 
determination of components in a mixture 
2. 
Several  analytical  methods  for  the 
determination  of  DOX  or  PYR  or  FA  are 
available  either  alone  or  in  combination  with 
other  drugs,  using  high-pressure  liquid 
chromatography  (HPLC) 
3-6, 
spectrophotometry 
7,8,  flow  injection-solid 
phase  spectrophotometry 
9,  potentiometric 
determination 
10,  spectrofluorometric 
determination 
11,12  and  capillary 
electrophoresis  methods 
13,14 
.
  Some  HPLC 
methods 
15,  16,  high  performance  thin  layer 
chromatography  (HPTLC) 
17  and  micellar 
liquid  chromatography  method 
18  have  been 
reported  for  the  determination  of  DOX  and 
PYR in combined dosage forms. A number of 
HPLC 
19,  20 and LC/UV/MS-MRM methods 
21 
for quantization of PYR and FA in multivitamin 
formulations  have  also  been  reported. 
Methods  like  first  derivative 
spectrophotometry,  ratio  spectra-zero-
crossing  and  double  divisor-ratio  spectra 
derivative have been studied for simultaneous 
determination of DOX, PYR, and FA 
22. 
In  this  paper,  we  have  reported  the 
investigation  and  development  of  rapid 
analytical  methodology  for  the  simultaneous 
determination of Doxylamine succinate (DOX), 
Pyridoxine hydrochloride (PYR) and Folic acid 
(FA).  The  methods  are  based  on  UV 
spectrophotometry,  and  the  resulting  heavily 
overlapping  responses  are  processed  by 
chemometrics.  The  application  of 
chemometrics  allows  the  interpretation  of 
multivariate data and is vital to the success of 
the simultaneous determination of the organic 
components. 
In this study, three chemometric methods 
have  been  successfully  applied  to  the 
simultaneous  determination  of  Doxylamine 
succinate  (DOX)  N,N-dimethyl-2-(1-phenyl-1-
(pyridin-2-yl)ethoxy)ethanamine succinate, an 
antiemetic  agent;  Pyridoxine  hydrochloride 
(PYR)  (5-hydroxy-6-methylpyridine-3,4-diyl) 
dimethanol  hydrochloride ,  an  anti-
inflammatory agent  and Folic acid (FA) (2S)-
2-[(4-{[(2-amino-4-hydroxypteridin-6-
yl)methyl]amino}phenyl)formamido]pentanedio
ic acid, a dietary supplement in a commercial 
tablet formulation, without any prior separation 
procedure.  Combination  of  these  drugs  is 
used to prevent morning sickness in pregnant 
women, for treatment of megaloblastic anemia 
and  in  anemias  of  nutritional  supplements, 
pregnancy, infancy, or childhood. 
 
MATERIALS AND METHODS 
 
Commercial  tablets  of  various  brands  like 
BOOKEY  PLUS  (Skymax  Laboratories  Pvt. 
Ltd.,  India);  LAMI-6  PLUS  (Srinivas  Gujarat 
Laboratories Pvt. Ltd., India) and VOMISAFE 
PLUS  (Kamron  Laboratories  Limited,  India) 
each  with  composition  (mg/tablet)  10  mg 
Doxylamine  Succinate  10  mg  Pyridoxine 
hydrochloride  and  2.5  mg  Folic  Acid  and 
NOMIT-OD  (Speciality  Meditech  Pvt.  Ltd., 
India)  with  composition  (mg/tablet)  20  mg 
Doxylamine  Succinate,  20  mg  Pyridoxine 
hydrochloride  and  2.5  mg  Folic  Acid  were 
taken  for  analysis.  Sodium  hydroxide  was 
purchased  from  Spectrochem  Pvt.  Ltd., 
(Mumbai,  India).  For  spectrophotometric 
analysis,  a  Shimadzu  UV-Vis  double  beam 
spectrophotometer equipped with 1 cm quartz 
cells  and  connected  to  personal  computer 
loaded UV Probe Ver.2.10 software was used. 
CLS,  ILS,  PCR,  and  PLS  analyses  were 
carried  out  using  the Chemometrics  Toolbox 
3.02  software  (Kramer,  1995)  for  use  with 
MATLAB  6.  The  visual  BASIC  program  of 
Wahbi  et  al.  (2005)  was  used  for  the 
differentiation of ratio data. Int J Pharm Bio Sci 2013 Jan; 4(1): (P) 738 - 749 
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Preparation  of  standard  solutions  and 
calibration 
For  spectrophotometric  measurement,  stock 
solution  (0.1  mg/ml)  of  DOX,  PYR  and  FA 
were prepared separately by dissolving 10 mg 
of  each  drug  in  100  ml  0.1M  NaOH.  The 
solutions were kept in amber colour flasks to 
protect  them  from  light.  The  zero  order  and 
first  derivative  absorption  spectra  were 
recorded over the wavelength range 220-400 
nm  against  the  solvent  blank.  The  dilutions 
were  made  in  0.1M  NaOH  to  obtain 
concentrations  ranging  from  5-60  µg/ml  for 
DOX, 2.5-30 µg/ml for PYR and 2.5-30 µg/ml 
for FA and their different synthetic mixtures by 
using  the  stock  solutions  and  linearity  was 
studied  at  respective  absorbance  i.e.  270, 
332.8  and  309.2  nm  for  DOX,  PYR  and  FA 
respectively.  
 
Preparation  of  ternary  mixtures  of  DOX, 
PYR and FA 
Appropriate  and  accurate  volume  aliquots  of 
the above stock solutions were transferred to 
the three sets of 10 ml calibrated flasks. The 
first series contained a constant concentration 
of PYR and FA (10 µg/ml each) and a varying 
concentration  of  DOX  (5–60  µg/ml).  The 
second contained a constant concentration of 
DOX  and  FA  (10  µg/ml)  and  a  varying 
concentration of PYR (2.5–30 µg/ml) and the 
third  series  contained  a  constant 
concentration of DOX and PYR (10 µg/ml) and 
a varying concentration of FA (2.5–30 µg/ml). 
The  solutions  were  protected  from  light 
throughout  the  study.  The  absorbance  data 
matrix  was  obtained  by  measuring  the 
absorbance at  16  wavelength  points  (251  to 
330  nm)  with  the  interval  of  5  nm  (delta 
lambda 5 nm) in spectral region between 250 
to 330 nm. 
A  calibration  set  of  21  mixtures  was 
prepared  in  methanol,  applying  a  multilevel 
multifactor  design  in  which  three  levels  of 
concentrations  of  DOX,  PYR  and  FA  within 
the stated range were introduced as shown in 
Table 1.  
A  validation  set  of  16  mixtures  was 
prepared  in  methanol,  applying  a  multilevel 
multifactor  design  in  which  three  levels  of 
concentrations  of  DOX,  PYR  and  FA  within 
the stated range were introduced as shown in 
Table 2.  
 
Table 1 
Composition of the concentration (calibration) set 
 
Number of  
Mixtures 
Concentration 
(µg/ml) 
DOX  PYR  FA 
1  5  10  10 
2  10  10  10 
3  20  10  10 
4  30  10  10 
5  40  10  10 
6  50  10  10 
7  60  10  10 
8  10  2.5  10 
9  10  5  10 
10  10  10  10 
11  10  15  10 
12  10  20  10 
13  10  25  10 
14  10  30  10 
15  10  10  2.5 
16  10  10  5 
17  10  10  10 
18  10  10  15 
19  10  10  20 
20  10  10  25 
21  10  10  30 Int J Pharm Bio Sci 2013 Jan; 4(1): (P) 738 - 749 
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Table 2 
Composition of the concentration (validation) set 
 
Number  of  
Mixtures 
Concentration 
 (µg/ml) 
DOX  PYR  FA 
1  5  10  10 
2  20  10  10 
3  40  10  10 
4  60  10  10 
5  10  2.5  10 
6  10  5  10 
7  10  15  10 
8  10  20  10 
9  10  30  10 
10  10  10  2.5 
11  10  10  5 
12  10  10  10 
13  10  10  15 
14  10  10  20 
15  10  10  25 
16  10  10  30 
 
Preparation of sample solutions 
In  spectrophotometric  methods,  20 
commercial  tablets  of  each  brand  (BOOKEY 
PLUS,  LAMI-6  PLUS,  VOMISAFE  PLUS, 
NOMIT-OD)  were  weighed  separately  and 
powdered in mortar. An amount of the powder 
equivalent to one tablet was taken in a 25 ml 
calibrated  volumetric  flask  and  dissolved  in 
0.1M  NaOH.  After  15  min  of  sonication,  the 
solution  was  filtered  through  Whatman  filter 
paper number 41. The volume was made up 
to 25 ml with 0.1M NaOH. Further dilutions of 
the  solution  were  made  with  0.1M  NaOH  to 
reach the calibration range. All the proposed 
chemometric  methods  were  applied  to  the 
solutions.  
 
Classical least squares (CLS) 
CLS is one of the simplest methods, based on 
a linear relationship between the absorbance 
and  the  component  concentrations  at  each 
wavelength. In matrix notation, the Beer’s law 
models for m calibration standards containing l 
chemical  components  with  spectra  of  n 
digitised absorbance is given by 
23,24,  
A=C×K+EA                                         (1) 
where  A  is  the  m  x  n  matrix  of  calibration 
spectra, C is the m x l matrix of component 
concentrations,  K  is  the  l  x  n  matrix  of 
absorbance-concentration  proportionality 
constants (absorptivity-pathlength), and EA is 
the  in  m  x  n  matrix  of  spectral  errors  or 
residuals not fit by the model. 
Inverse least squares (ILS) 
This method treats concentration as a function 
of  absorbance.  The  inverse  of  Beer’s  law 
model for m calibration standards with spectra 
of n digitised absorbance is given by 
25, 26:   
C=A×P+Ec                                              (2)  
Where C and A are as before, P is the n × l 
matrix  of  unknown  calibration  co-efficient 
relating the l component concentrations of the 
spectral intensities, and Ec is the m × l vector 
of  errors.  Since  in  ILS  the  number  of 
wavelengths cannot exceed the total number 
of calibration mixtures, stepwise multiple linear 
regressions have been used for the selection 
of wavelengths.  
 
Principal component regression (PCR) 
In the spectral work, the following steps can 
explain the fundamental concept of PCR
 27.  
(a) The original data obtained in absorbances 
(A)  and  concentrations  (C)  of  analytes  have 
been  reprocessed  by  mean-centring  as  A0 
and C0, respectively. 
(b)  The  covariance  dispersion  matrix  of  the 
centered  matrix  A0  was  computed.  The 
normalized  eigenvalues  and  eigenvectors 
were  calculated  starting  from  square 
covariance matrix. The number of the optimal 
principal  components  (eigenvectors)  is 
selected  by  considering  only  the  highest 
values  of  the  eigenvalues.  The  other 
eigenvalues  and  their  corresponding 
eigenvectors  are  eliminated  from  our  study. Int J Pharm Bio Sci 2013 Jan; 4(1): (P) 738 - 749 
 
 
This article can be downloaded from www.ijpbs.net 
P - 742 
Using the ordinary linear regression C = a + b 
x A, we calculated the coefficients a and b. To 
reach this objective firstly we determined the 
coefficient  b  as  b  =  P  x  q,  where  P  is  the 
matrix of eigenvectors and q is the C-loadings 
given  by  q  =  D  x  T
T  x  A0.  Here  T
T  is  the 
transpose  of  the  score  matrix  T.  D  is  a 
diagonal matrix having on the components the 
inverse of the selected eigenvalues. Knowing 
b we can easily find a by using the formula a = 
Cmean — A
T
mean x b, where A
T
mean represents 
the transpose of the matrix having the entries 
of the mean absorbance values and Cmean is 
the mean concentration of the calibration set. 
 
Partial least squares (PLS) 
The  PLS  calibration  technique  using  the 
orthogonalized  PLS  algorithm  developed  by 
Wold
28,  29  and  extensively  discussed  by 
Martens and Naes 
30 involves simultaneously 
the independent and the dependent variables 
on  the  data  compression  and  decomposition 
operations. 
In  the  UV-Vis  spectra,  the  absorbance  data 
(A)  and  concentration  data  (C)  are  mean 
centred to give data matrix A0 and vector C0. 
The  orthogonalized  PLS  algorithm  has  the 
following steps 
31: 
(a) The  loading  weight  vector  W  has  the 
following expression: 
 W = A′0C0/C′0C0                 (3) 
(b) The scores and loadings are given by: 
t1 = A0W1, 
P1 = (A0
T t1))/(t1
T t1), 
q1 = (C0
T t1)/(t1
T t1),                                     (4) 
(c)  The matrix and vector of the residuals in 
A0 and C0 are: 
 A1 = A0 – t1 P1
T, 
C1 = C0 – t1 q1
T,                                          (5) 
 (d)  From  the  general  linear  equation,  the 
regression coefficients were calculated by: 
b = W (P
T W)
-1 q,                                        (6) 
a=Cmean – A
T
mean b,                                     (7) 
As  in  PCR  method,  the  builded  calibration 
equation  is  used  for  the  estimation  of  the 
compounds in the samples. 
 
RESULTS AND DISCUSSION 
 
 
 
Figure 1 
Overlain zero order spectra of (a) DOX (15 µg/ml), (b) PYR (15 µg/ml) and (c) FA (15 µg/ml). 
 
Figure 1 shows the zero-order overlay spectra 
of  DOX,  PYR  and  FA  as  well  as  their 
corresponding ternary mixture in 0.1 M NaOH. 
As shown in the Figure 1 the spectra of DOX, 
PYR and FA are overlapped in the region of 
their  absorption  maxima.  Direct  ultraviolet 
spectrophotometry  cannot  be  used  to 
determine  the  two  compounds  individually  in 
their  mixtures  but  the  chemometric  method 
seemed  to  offer  great  potential.  For  this 
reason  to  solve  overlapped  spectra,  four 
chemometric calibrations using the zero-order 
spectra have been applied. 
 
Multivariate calibration 
The  calibration  set  of  21  standard  mixture 
solutions  which  contain  the  concentrations 
with different ratio of DOX, PYR and FA was 
randomly prepared within the linearity range of 
three  drugs.  The  UV  absorbance  data  was 
obtained by measuring the absorbances in the 
region of 250-330 nm. By using the correlation Int J Pharm Bio Sci 2013 Jan; 4(1): (P) 738 - 749 
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between  calibration  concentrations  and  its 
absorbance  data,  the  chemometric 
calibrations  were  calibrated  within  the  CLS, 
ILS, PCR and PLS algorithms.  
The quality of multi-component analysis is 
dependent on the wavelength range, spectral 
mode  used,  calibration  set  chosen  and 
calibration range. All the information present in 
the  sample  target  should  be  present  in  the 
calibration  data  set.  It  has  been  one  of  the 
main  drawbacks  in  development  studies  of 
multivariate method. Except ILS the remaining 
CLS,  PCR  and  PLS  techniques  are 
designated  as  full  spectrum  computational 
procedures,  thus  wavelength  selection  is 
seemingly  unnecessary,  and  so  all  available 
wavelengths are often used. Stepwise multiple 
linear  regressions  have  been  used  for  the 
selection of frequencies in ILS. 
 
Statistical parameter 
The  predictive  applicability  of  a  regression 
model is described in various ways. The most 
general  expression  is  the  standard  error  of 
prediction  (SEP)  and  standard  error  of 
calibration denoted by SEC which is given in 
the following formula;  
n
C C
Found
i
N
i
Added
i
2
1 ) (
  (SEC)   SEP
−
= ∑ =  
Here 
Added
i C   is  the  added  concentration  of 
drugs, 
Found
i C is the predicted concentration of 
drugs  and  n  is  the  total  number  of  the 
synthetic mixtures. The SEP and SEC results 
and  other  statistical  evaluations  obtained  by 
applying CLS, ILS, PCR and PLS to the above 
mentioned  validation  set  of  the  synthetic 
mixtures are quoted in Table 3. 
 
Table 3 
Statistical parameters of chemometric methods in calibration step of Zero-order spectra 
 
 
Component 
CLS  ILS  PCR  PLS 
SEC
a  SEP
b  SEC  PRESS
c  RSE  SEC  PRESS  RSE 
DOX  0.1928  0.1849  0.0154  0.0047  0.0669  0.0151  0.0045  0.0656 
PYR  0.1617  0.1463  0.0391  0.0306  0.2882  0.0364  0.0265  0.2684 
FA  0.1434  0.1124  0.0182  0.0066  0.1344  0.0183  0.0067  0.2684 
                                  aSEC=Standard error of calibration 
                                   bSEP=Standard error of prediction 
                                   cPRESS= Prediction residual error sum of squares 
 
Selection of optimum number of factors for 
PCR and PLS 
For  PCR  and  PLS  methods,  21  calibration 
spectra  were  used  for  the  selection  of  the 
optimum number of factors by using the cross 
validation technique. This allows modelling of 
the  system  with  the  optimum  amount  of 
information  and  avoidance  of  overfitting  or 
underfitting.  The  cross-validation  procedure 
consists of systematically  removing one of a 
group  of  training  samples  in  turn  and  using 
only the remaining ones for the construction of 
latent  factors  and  applied  regression.  The 
predicted concentrations were then compared 
with the actual ones for each of the calibration 
samples and mean squares error of prediction 
(MSEP)  was  calculated.  The  MSEP  was 
computed  in  the  same  manner  each  time  a 
new  factor  was  added  to  the  PCR  and  PLS 
model. The selected model was that with the 
fewest number of factors such that its MSEP 
values were not significantly greater than that 
for the model, which yielded the lowest MSEP. 
A  plot  of  MSEP  values  against  number  of 
components  (Figure  2  and  3  indicates  that 
factor  five  and  four  were  optimum  for  the 
estimation of principle ingredients by PLS and 
PCR). At the selected principal components of 
PLS  and  PCR  the  concentrations  of  each 
sample  were  then  predicted  and  compared 
with  known  concentration  and  the  PRESS 
(prediction residual error sum of squares) was 
calculated.  PRESS  value  was  calculated  as 
the  difference  between  the  real  and  the 
calculated  concentrations,  squared  and 
summed,  over  all  references  for  each 
component. It was given by this equation, and 
values are indicated in Table 3.  Int J Pharm Bio Sci 2013 Jan; 4(1): (P) 738 - 749 
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Figure 2 
MSEP plots of a calibration set obtained using leave-one-out (LOO) cross validation of PLS-
model for (A) DOX, (B) PYR and (C) FA in zero-order absorption data. 
 
       
 
 
Figure 3 
MSEP plots of a calibration set obtained using leave-one-out (LOO) cross validation of 
PCR-model for (A) DOX, (B) PYR and (C) FA in zero-order absorption data. 
Validation of the developed methods Int J Pharm Bio Sci 2013 Jan; 4(1): (P) 738 - 749 
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To check the validity (predictive ability) of the 
calibration models, the simultaneous analysis 
of the prediction set containing 16 samples of 
various concentrations (in triplicates) of DOX, 
PYR and FA were carried out. The maximum 
values  of  the  mean  percent  errors 
corresponding to CLS, ILS, PCR and PLS for 
the  same  mixtures  were  completely 
acceptable  because  of  their  very  smallest 
values. The mean recoveries and the relative 
standard deviations of our proposed methods 
were  computed  and  indicated  in  Table  4-7. 
Their  numerical  values  were  completely 
acceptable  because  of  their  smallest  values 
and hence found satisfactory for the validity of 
all calibration methods.  
The linearity of the proposed chemometric 
method  for  determination  of  DOX,  PYR  and 
FA  was  evaluated  by  analysing  a  series  of 
different concentrations of standard drug. The 
linearity was found to be ranging between 5-
60 µg/ml for DOX and 2.5-30 µg/ml for both 
PYR  and  FA.  Each  concentration  was 
repeated three times.  
The accuracy study was performed by  
increasing  standard  addition  of  known 
amounts  of  studied  drugs  to  an  unknown 
concentration  (constant  volume)  of  the 
commercial  pharmaceutical  formulations.  A 
constant volume of the unknown solution was 
added to each of six 10 ml volumetric flasks. 
Then  a  series  of  increasing  volumes  of 
working  standard  solutions  were  added. 
Finally, each flask was made up to the mark 
with 0.1M NaOH and mixed well. The resulting 
mixtures  were  analyzed  and  chemometric 
recoveries  were  determined.  The  results 
obtained  were  compared  with  expected 
results.  The  good  mean  recoveries  and 
standard deviation Table 4-7 suggested good 
accuracy  of  the  proposed  methods  and  no 
interference from formulations excipients. The 
selectivity  of  the  proposed  method  was  also 
assessed  by  the  analysis  of  synthetic 
mixtures,  where  satisfactory  results  were 
obtained  over  the  stated  calibration  range
. 
Table 4 
Analysis of validation set by CLS method 
 
Added Conc.  
(µg/ml) 
Measured conc.* 
 (µg/ml)  Recovery (%) 
DOX  PYR  FA  DOX  PYR  FA  DOX  PYR  FA 
5  10  10  4.99  10.05  10.04  99.81  100.46  100.42 
20  10  10  20.06  10.02  9.99  100.30  100.19  99.89 
40  10  10  40.08  9.98  10.02  100.21  99.80  100.17 
60  10  10  59.54  10.01  9.69  99.24  100.06  96.90 
10  2.5  10  10.00  2.20  10.16  99.97  101.82  101.58 
10  5  10  10.10  5.06  10.01  100.95  101.17  100.14 
10  10  10  9.89  9.97  10.10  98.87  99.72  100.98 
10  20  10  9.85  19.55  9.87  98.49  97.76  98.66 
10  30  10  9.54  30.29  9.90  95.35  100.97  99.05 
10  10  2.5  10.01  10.01  2.08  100.06  100.05  101.11 
10  10  5  9.82  10.07  5.14  98.23  100.68  102.72 
10  10  15  9.96  9.89  14.99  99.60  98.90  99.92 
10  10  20  9.72  9.90  19.78  97.23  98.98  98.92 
10  10  25  9.51  9.87  24.84  95.11  98.72  99.37 
10  10  30  9.81  9.75  29.90  98.09  97.54  99.68 
Mean 
RSD (%) 
98.77  99.79  99.97 
1.76  1.22  1.37 
          *Mean of three individual determinations 
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Table 5 
Analysis of validation set by ILS method 
 
 
Added Conc. 
(µg/ml) 
 
Measured conc.* 
(µg/ml) 
Recovery (%) 
DOX  PYR  FA  DOX  PYR  FA  DOX  PYR  FA 
5  10  10  5.00  10.09  10.13  99.95  100.89  101.33 
20  10  10  20.12  10.05  10.03  100.61  100.49  100.33 
40  10  10  40.20  9.94  10.14  100.51  99.42  101.39 
60  10  10  59.79  10.02  9.76  99.65  100.16  97.61 
10  2.5  10  9.92  2.55  10.18  99.15  100.18  101.79 
10  5  10  10.36  5.03  10.09  103.58  100.67  100.87 
10  10  10  10.22  10.00  10.17  102.17  100.00  101.66 
10  20  10  9.85  19.84  9.90  98.49  99.19  99.02 
10  30  10  10.04  30.37  9.92  100.36  101.24  99.16 
10  10  2.5  10.12  10.00  2.63  101.23  100.00  103.36 
10  10  5  10.13  10.09  5.16  101.28  100.93  103.12 
10  10  15  10.25  10.02  15.00  102.51  100.22  99.97 
10  10  20  10.17  10.05  19.91  101.75  100.46  99.54 
10  10  25  9.79  9.98  24.87  97.94  99.77  99.49 
10  10  30  9.97  9.97  29.98  99.67  99.66  99.92 
Mean 
RSD (%) 
100.59  100.22  100.57 
1.53  0.58  1.56 
*Mean of three individual determinations 
 
Table 6 
Analysis of validation set by PCR method 
 
 
Added Conc.  
(µg/ml) 
 
Measured conc.* 
 (µg/ml) 
Recovery (%) 
DOX  PYR  FA  DOX  PYR  FA  DOX  PYR  FA 
5  10  10  4.84  10.04  9.83  96.80  100.39  98.32 
20  10  10  19.97  10.03  9.86  99.83  100.27  98.59 
40  10  10  40.04  10.03  9.96  100.11  100.26  99.61 
60  10  10  59.55  10.11  9.67  99.25  101.06  96.73 
10  2.5  10  9.81  2.64  9.91  98.13  105.55  99.15 
10  5  10  9.92  5.02  9.78  99.22  100.47  97.79 
10  10  10  9.76  9.97  9.91  97.61  99.71  99.13 
10  20  10  9.85  19.63  9.73  98.47  98.15  97.33 
10  30  10  9.56  30.45  9.85  95.59  101.51  98.54 
10  10  2.5  9.81  9.97  2.50  98.08  99.66  100.09 
10  10  5  9.63  10.05  4.87  96.34  100.52  97.36 
10  10  15  9.87  9.92  14.84  98.72  99.22  98.93 
10  10  20  9.68  9.96  19.69  96.81  99.57  98.44 
10  10  25  9.54  9.94  24.83  95.36  99.39  99.33 
10  10  30  9.84  9.89  29.90  98.39  98.90  99.65 
Mean 
RSD (%) 
97.91  100.31  98.60 
1.50  1.68  0.98 
*Mean of three individual determinations 
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Table 7 
Analysis of validation set by PLS method 
 
 
Added Conc. 
(µg/ml) 
 
Measured conc.* 
(µg/ml) 
Recovery (%) 
DOX  PYR  FA  DOX  PYR  FA  DOX  PYR  FA 
5  10  10  4.79  9.93  9.80  95.71  99.32  97.99 
20  10  10  19.92  9.94  9.84  99.61  99.35  98.36 
40  10  10  40.01  9.95  9.94  100.02  99.48  99.40 
60  10  10  59.55  10.12  9.66  99.25  101.22  96.64 
10  2.5  10  9.75  2.50  9.88  97.48  99.99  98.83 
10  5  10  9.86  4.88  9.75  98.56  97.69  97.45 
10  10  10  9.73  9.92  9.89  97.33  99.23  98.90 
10  20  10  9.91  19.81  9.74  99.06  99.04  97.40 
10  30  10  9.46  30.26  9.79  94.57  100.86  97.86 
10  10  2.5  9.82  9.99  2.50  98.18  99.90  100.08 
10  10  5  9.65  10.08  4.87  96.47  100.82  97.34 
10  10  15  9.80  9.80  14.79  98.02  97.98  98.60 
10  10  20  9.62  9.87  19.64  96.24  98.68  98.21 
10  10  25  9.48  9.87  24.78  94.81  98.66  99.13 
10  10  30  9.76  9.78  29.83  97.65  97.77  99.44 
                                                       Mean 
RSD (%) 
97.53  99.33  98.38 
1.73  1.10  0.96 
*Mean of three individual determinations 
 
CONCLUSION 
 
Many drugs have come up in combinations in 
order  to  improvise  the  therapy  of  various 
ailments. These combinations have forged a 
challenge to use a simple method to estimate 
the  individual  drugs  in  combination  with 
respect  of  time  and  complexity.  
Simultaneous  determination  of  DOX,  PYR 
and  FA  in  tablet  is  not  reported  in  the 
literature  as  yet.  We  attempted  to  develop 
four  chemometric  methods  i.e.  CLS,  ILS, 
PCR and PLS. We found them to be simple, 
precise,  accurate,  rapid  and  economical 
methods  for  their  simultaneous 
determination.  The  methods  were 
successfully validated and found suitable for 
quality control laboratories.     
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